its capital investment as well as any stranded costs through rate-base increases. Daniel Rohr, Joscelyn Mackay, Julie Stralow , Michael Hodel, Jim Leonard, Rick Tauber, Jeff Cannon, Min Tang-Varner, and Joseph DeSapri contributed to this
qualities if indeed we're looking at an extended period of weakness for Europe. Daniel Rohr, Joscelyn Mackay, Julie Stralow , Michael Hodel, Jim Leonard, Rick Tauber, Jeff Cannon, Min Tang-Varner, Joseph DeSapri, Travis Miller, and
By Morningstar : By Julie Stralow , CFA Orthopedic industry moat trends are declining as a result of increasing regulatory and reimbursement pressures, and ongoing
Julie Stralow : Hello, I'm Julie Stralow , equity analyst at Morningstar. Today, we have Phil Cowdy here from Smith & Nephew. Smith & Nephew is one of the top innovators in the orthopedic device industry. However, shares have been constrained
upgrade and driving spread tightening as investment-grade buyers move into the name. Daniel Rohr, Joscelyn Mackay, Julie Stralow , Michael Hodel, Jim Leonard, Rick Tauber, Jeff Cannon, Min Tang-Varner, Travis Miller, and Jason Stevens also
managed care. Today it's my great pleasure to welcome Julie Stralow to talk about how health-care reform will affect device companies. Julie, thanks for coming. Julie Stralow : No problem, good to be here. Kobayashi-Solomon
By Morningstar : by Julie Stralow , CFA For the past couple years, the Food and Drug Administration has been reviewing the regulatory process that most medical
higher than POSCO, the prevailing spread between the two firms' bonds seems too wide. Daniel Rohr, Joscelyn Mackay, Julie Stralow , Michael Hodel, Jim Leonard, Rick Tauber, Jeff Cannon, Min Tang-Varner, Travis Miller, and Jason Stevens also
of peer Arch Coal's 7.25% notes of 2020 (T+329 bps to Oct 18 call @100). Daniel Rohr, Joscelyn Mackay, Julie Stralow , Michael Hodel, Patrick Goff, Rick Tauber, Jeff Cannon, Min Tang-Varner and James Sinegal also contributed to
services, especially health care, we could see a period of GDP improvement even as total consumption moderates. Julie Stralow , a senior health-care analyst at Morningstar, noted that orthopedic supplier Stryker SYK had a better-than